Medtronic (MDT) stock hit with 2 downgrades after disappointing results, guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Medtronic, Inc. (MDT) PT Lowered to $84 at Truist Securities
November 23, 2022 7:38 AM ESTTruist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $84.00 (from $89.00) while maintaining a Hold rating.... More
Medtronic, Inc. (MDT) PT Lowered to $82 at JPMorgan
November 23, 2022 7:22 AM ESTJPMorgan analyst Robbie Marcus lowered the price target on Medtronic, Inc. (NYSE: MDT) to $82.00 (from $95.00) while maintaining a Neutral rating.... More
Medtronic, Inc. (MDT) PT Lowered to $82 at Wells Fargo
November 23, 2022 7:20 AM ESTWells Fargo analyst Larry Biegelsen lowered the price target on Medtronic, Inc. (NYSE: MDT) to $82.00 (from $96.00) while maintaining a Equal Weight rating.... More
Medtronic, Inc. (MDT) PT Lowered to $102 at RBC Capital
November 23, 2022 6:29 AM ESTRBC Capital analyst Shagun Singh lowered the price target on Medtronic, Inc. (NYSE: MDT) to $102.00 (from $110.00) while maintaining a Outperform rating.... More
Medtronic, Inc. (MDT) PT Lowered to $80 at Wolfe Research
November 23, 2022 3:18 AM ESTWolfe Research analyst Mike Polark lowered the price target on Medtronic, Inc. (NYSE: MDT) to $80.00 (from $85.00) while maintaining a Underperform rating.... More
Medtronic slumps as annual outlook hurt by forex, slow recovery
November 22, 2022 11:10 AM ESTBy Khushi Mandowara and Bhanvi Satija
(Reuters) -Medtronic Plc on Tuesday lowered its full-year outlook for profit and revenue growth, blaming a stronger dollar and a slower-than-anticipated recovery in supply chain disruptions, sending the medical device maker's shares down nearly 6%.
Rivals including Boston Scientific Corp and Stryker have also recently lowered their full-year profit forecast and cautioned about the persistence of supply chain constraints and the... More
Medtronic dips on miss and lower guidance from slow procedure and supply recovery
November 22, 2022 9:01 AM ESTMedtronic (NYSE: MDT) fell nearly 5% in pre-open trading Tuesday following a miss on the top-line for the second quarter and lower full-year guidance.
The medical device maker reported that revenue fell 3% to $7.6 billion, missing the Wall Street consensus of $7.7 billion. The company said the results reflect "slower supply recovery or lower than anticipated underlying market procedure volumes in certain businesses and... More
